Skip to main content

Monte Rosa Therapeutics, Inc. insider trading

GLUENASDAQ
$10.50-0.76 (-6.75%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+37.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • ABAli BehbahaniDirector7.8444%of company
  • MWMarkus WarmuthPresident & CEO0.6858%of company
  • STSharon TownsonChief Scientific Officer0.0795%of company
  • JCJennifer ChampouxChief Operating Officer0.0731%of company
  • FJFilip JankuChief Medical Officer0.071%of company
  • PNPhilip NicksonChief Business & Legal Officer0.0645%of company
  • MBMatthew BowenPrincipal Accounting Officer0.0304%of company
  • EDEdmund DunnPrincipal Accounting Officer0.0264%of company
  • CPChandra P. LeoDirector0.0117%of company
  • AMAnthony M. ManningDirector0.00%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
GLUEMarkus WarmuthPresident & CEOOpen market sell$220K-1.6%$23.18$220KJul 16, 2026Jul 17, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$9.23K-0.1%$19.73$9.23KJun 1, 2026Jun 2, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$97K-0.8%$19.41$97KJun 1, 2026Jun 2, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$103K-0.9%$18.92$103KMay 1, 2026May 5, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$141K-1.3%$17.64$141KApr 14, 2026Apr 15, 2026
GLUEPhilip NicksonChief Business & Legal OfficerOpen market sell$103K-9.6%$17.69$103KApr 9, 2026Apr 10, 2026
GLUEEdmund DunnPrincipal Accounting OfficerOpen market sell$2.5K-0.6%$17.96$2.5KMar 4, 2026Mar 5, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$98K-0.9%$17.92$98KMar 2, 2026Mar 4, 2026
GLUEFilip JankuChief Medical OfficerOpen market sell$179K-12.3%$19.50$179KFeb 23, 2026Feb 24, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$7.59K-0.1%$24.57$7.59KJan 7, 2026Jan 9, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$34.6K-0.2%$23.88$34.6KJan 7, 2026Jan 9, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$86.2K-0.6%$23.24$86.2KJan 7, 2026Jan 9, 2026
GLUEPhilip NicksonChief Business & Legal OfficerOpen market sell$47.9K-4.9%$15.17$47.9KJan 5, 2026Jan 5, 2026
GLUEJennifer ChampouxChief Operating OfficerOpen market sell$39.9K-4.0%$15.17$39.9KJan 5, 2026Jan 5, 2026
GLUEEdmund DunnPrincipal Accounting OfficerOpen market sell$15.8K-4.4%$15.17$15.8KJan 5, 2026Jan 5, 2026
GLUEMarkus WarmuthPresident & CEOOpen market sell$154K-1.6%$15.17$154KJan 5, 2026Jan 5, 2026
GLUEFilip JankuChief Medical OfficerOpen market sell$47.9K-4.0%$15.17$47.9KJan 5, 2026Jan 5, 2026
GLUESharon TownsonChief Scientific OfficerOpen market sell$47.9K-4.4%$15.17$47.9KJan 5, 2026Jan 5, 2026
End of history · 18 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.